Results 161 to 170 of about 9,156 (240)

Toward Image-Guided, Robot-Assisted Focal Prostate Resection: Do Enhanced Dexterity and Visualization Improve Performance? [PDF]

open access: yesJ Med Robot Res
d'Almeida JF   +13 more
europepmc   +1 more source

The first United States prospective trial using the Hugo™ robot‐assisted surgery system

open access: yesBJU International, Volume 138, Issue 1, Page 85-91, July 2026.
Objective To describe the safety and effectiveness of the Hugo™ robot‐assisted surgery (RAS) system (Medtronic, Minneapolis, MN, USA) when used for three urological procedures. Patients and Methods The Expand URO (ClinicalTrials.gov identifier: NCT05696444) was the first investigational study for the Hugo RAS system based in the United States. It was a
Michael R. Abern   +14 more
wiley   +1 more source

Distinct Prescription Patterns Emerge Years Before ALS Diagnosis: A Nationwide Registry‐Based Study

open access: yesAnnals of Neurology, Volume 99, Issue 6, Page 1516-1525, June 2026.
Objective The prodromal phase of amyotrophic lateral sclerosis (ALS) is poorly defined. We aimed to characterize prescription drug use patterns in the pre‐diagnostic period by analyzing nationwide prescription data to identify the earliest divergence between individuals who developed ALS and matched healthy controls.
Magne Haugland Solheim   +6 more
wiley   +1 more source

Intraoperative Diagnosis and Management of Testicular Dislocation During Pelvic Fracture Fixation: A Report of Two Cases and Literature Review. [PDF]

open access: yesJ Orthop Case Rep
Agelet-Pueyo A   +4 more
europepmc   +1 more source

1H MR‐based detection of human plasma metabolic alterations in clear cell renal cell carcinoma

open access: yesBJUI Compass, Volume 7, Issue 6, June 2026.
Abstract Objectives This study aimed to evaluate the potential of plasma‐based proton magnetic resonance spectroscopy (1H‐MRS) for non‐invasive discrimination between clear cell renal cell carcinoma (ccRCC), benign renal masses (angiomyolipoma and oncocytoma) and healthy controls by identifying disease‐specific metabolic signatures.
Raj Kumar Sharma   +6 more
wiley   +1 more source

Multicentre real‐world evaluation of the Haematuria Cancer Risk Score to risk‐stratify the detection of bladder cancer in patients referred from primary care

open access: yesBJUI Compass, Volume 7, Issue 6, June 2026.
Abstract Objectives To investigate the potential of the Haematuria Cancer Risk Score (HCRS) to improve the real‐world investigation pathway for suspected bladder cancer. Materials and methods Data were retrospectively analysed for all consecutive patients referred with suspected urinary tract cancer on a faster diagnostic pathway to five UK ...
Tom Malik   +19 more
wiley   +1 more source

DaRenCa risk score: A prognostic model for recurrence in clear cell renal cell carcinoma

open access: yesBJUI Compass, Volume 7, Issue 6, June 2026.
Abstract Objective This study aimed to investigate whether a machine‐learning model improves the assessment of postsurgical recurrence‐free survival in patients with non‐metastatic clear cell renal cell carcinoma (ccRCC) compared with a Cox proportional hazards (CPH) approach. Patients and Methods Patients undergoing curative surgery for non‐metastatic
Philip Hedegaard   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy